Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)-Reference-Cited by-同舟云学术

Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)

Published:2018-02-27 Issue:6 Volume:33 Page:809-817
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Kosugi Chihiro^ORCID,Koda Keiji,Ishibashi Keiichiro,Yoshimatsu Kazuhiko,Tanaka Soichi,Kato Ryouji,Kato Hiroyuki,Oya Masatoshi,Narushima Kazuo,Mori Mikito,Shuto Kiyohiko,Ishida Hideyuki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00384-018-2979-9/fulltext.html

Reference23 articles.

1. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, KrooK JE, Malliard J, Twito DI, Morton RF, Tschetter LK, Barlow JF (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7:1447–1456

2. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA (1990) Lavaisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358

3. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11:1879–1887

4. International Multicentre Pooled Analysis of Colon Cancer Trial (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939–944

5. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899–906

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer;The Journal of Medical Investigation;2024

2. Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation;World Journal of Clinical Cases;2021-11-16

3. Multicenter phase II clinical study of the efficiency and safety of capecitabine plus intermittent oxaliplatin with bevacizumab as first-line therapy in patients with metastatic colorectal cancer (VOICE trial);International Journal of Colorectal Disease;2021-08-09

4. Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study;Journal of Gastrointestinal Oncology;2021-08

5. The updated five-year overall survival and long-term oxaliplatin-related neurotoxicity assessment of the FACOS study;Surgery Today;2021-02-14